Drugs could boost breast cancer surgery outcomes

22 December 2014

Surgery to help women with triple-negative breast cancer could be boosted by either a chemotherapy drug or one that targets blood vessels, a new study has claimed.

A breast cancer specialist and clinical researcher at Women & Infants Hospital of Rhode Island presented his research at the 2014 San Antonio Breast Cancer Symposium, which found that these drugs were able to increase the proportion of women who had no residual cancer detected at surgery.

Dr William Sikov, associate chief of clinical research with the Program in Women's Oncology at Women & Infants and associate professor of medicine at The Warren Alpert Medical School of Brown University, said the study also found one of the drugs also worked in a similar way for women with nonbasal-like cancers.

Along with a team, Dr Sikov conducted a randomised, phase II clinical trial that tested one of two drugs for 443 women undergoing standard preoperative chemotherapy. All participants had operable stage II or III triple-negative breast cancer, and the results are based on analysis of tissue samples obtained before patients started treatment, correlated with findings at surgery after treatment.

Posted by ​Jeanette Royston​


Health News is provided by Adfero in collaboration with Spire Healthcare. Please note that all copy above is ©Adfero Ltd. and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.


Find a treatment, test or scan available at:


Find a consultant

Use one or more of the options below to search for a consultant and link through to view their Spire profile.


Let us help you

fill out this form and we will get back to you:

Please select a hospital

We can call you

Please enter your details below and we will call you back.

What is the aim of your enquiry?

Please select a hospital

If we are unable to reach you by phone, please include your email address so that we can get in touch...



© Spire Healthcare Group plc (2016)